Pharmaceutical
| Tue 05 May 2026
Geneva, May 5 -- Antharis Therapeutics Inc has sought patent for FLT3-binding Antibodies and Methods of Use Thereof. This invention was developed by Ribeiro-pinaud Raphael, Xia Jinming, Sjoberg Eric, Hoff Robert, Seyedi Seyedehsareh, Han Jerome, Suraparaju Sai, Kowalski Dominic, Dwyer Mary and Yazbeck Daniel.
The patent appli..